학술논문

Correction to: Brigatinib in Japanese patients with tyrosine kinase inhibitor-naive ALK-positive non-small cell lung cancer: first results from the phase 2 J-ALTA study
Document Type
Erratum
Source
International Journal of Clinical Oncology. 28(5):724-725
Subject
Language
English
ISSN
1341-9625
1437-7772